Skip to Main Content

Author Details

Bruce R Basson
Lilly Research Laboratories
2000
20
15
PMIDPaper TitleJournal TitlePublished Year
22683137Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.Lancet2012
22790642Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors.J Androl2012
17467848A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).Lung Cancer2007
16352692The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis.J Clin Endocrinol Metab2006
15602111Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients.Int Clin Psychopharmacol2005
16145426Effect of tadalafil on sexual timing behavior patterns in men with erectile dysfunction: integrated analysis of randomized, placebo controlled trials.J Urol2005
16259550Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania?J Clin Psychiatry2005
15025782Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].Crit Care2004
15550023Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.J Thromb Haemost2004
15306109Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.Eur Urol2004
12544986Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.Crit Care Med2003
14515185Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.Thromb Haemost2003
12869495Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.Blood2003
12712239Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.Intensive Care Med2003
12626993Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.Crit Care Med2003
11379836Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.J Clin Psychiatry2001
11232752Weight change and atypical antipsychotic treatment in patients with schizophrenia.J Clin Psychiatry2001
11247108Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.J Clin Psychiatry2001
11105736Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.J Clin Psychiatry2000
15014645The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone.Prim Care Companion J Clin Psychiatry2000
  • 1 - 20 of 20

Recommended Authors

Cristiano Noto
Universidade Federal de Sao Paulo
Career Start Year 2011
Number of shared co-authors 0
Rita Khoury
Saint Louis University
Career Start Year 2009
Number of shared co-authors 0
Michelle Rainka
From the Dent Neurologic Institute
Career Start Year 2008
Number of shared co-authors 0
Dana D Nguyen
University of California Irvine
Career Start Year 2005
Number of shared co-authors 0
Douglas J Hsu
Beth Israel Deaconess Medical Center
Career Start Year 2003
Number of shared co-authors 0
Xin-Qun Wang
University of Virginia Health System
Career Start Year 2001
Number of shared co-authors 0
Shane Raines
AstraZeneca Pharmaceuticals
Career Start Year 2000
Number of shared co-authors 0
Susan G Leckband
VA San Diego Healthcare System
Career Start Year 1999
Number of shared co-authors 0
Adrian Preda
University of California Irvine
Career Start Year 1998
Number of shared co-authors 0
Mazda Adli
Center for Psychiatry
Career Start Year 1998
Number of shared co-authors 0
Brian C Lund
Center for Access and Delivery Research and Evaluation (CADRE)
Career Start Year 1998
Number of shared co-authors 0
Douglas Hayden
Massachusetts General Hospital.
Career Start Year 1997
Number of shared co-authors 3
Stephen R Wisniewski
Graduate School of Public Health, University of Pittsburgh
Career Start Year 1994
Number of shared co-authors 0
Balwinder Singh
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Roy H Perlis
Center for Quantitative Health, Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 0
Allan H Young
Institute of Psychiatry, King's College London
Career Start Year 1991
Number of shared co-authors 0
Michael Bauer
Carl Gustav Carus University Hospital, Technische Universitat Dresden
Career Start Year 1990
Number of shared co-authors 0
Mark A Frye
The Mayo Clinic
Career Start Year 1989
Number of shared co-authors 0
Shahrokh Golshan
University of California
Career Start Year 1988
Number of shared co-authors 0
Lakshmi N Yatham
University of British Columbia
Career Start Year 1987
Number of shared co-authors 0
Andrew A Nierenberg
Massachusetts General Hospital, United States Harvard University
Career Start Year 1986
Number of shared co-authors 0
Jacques Demotes-Mainard
The European Clinical Research Infrastructure Network (ECRIN)
Career Start Year 1986
Number of shared co-authors 1
Susan L McElroy
University of Cincinnati
Career Start Year 1986
Number of shared co-authors 0
Christopher M Frampton
University of Otago
Career Start Year 1986
Number of shared co-authors 0
Muhammad Mamdani
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 0
Laura J Fochtmann
Stony Brook University
Career Start Year 1979
Number of shared co-authors 0
Bruce M Cohen
Harvard Medical School
Career Start Year 1979
Number of shared co-authors 0
Steven G Potkin
University of California Irvine
Career Start Year 1977
Number of shared co-authors 0
David A Schoenfeld
Mass General Hospital
Career Start Year 1977
Number of shared co-authors 5
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Jean-Fran??ois Dhainaut
Universite Paris Descartes
Co-authored papers 5
Pierre-Fran??ois Laterre
Centre Hospitalier Regional Mons-Hainaut
Co-authored papers 3
Gordon R Bernard
Vanderbilt University
Co-authored papers 3
Jean-Louis Vincent
Erasme Hospital, Universite Libre de Bruxelles
Co-authored papers 3
James A Russell
St. Paul's Hospital, University of British Columbia
Co-authored papers 2
Derek C Angus
University of Pittsburgh Medical Center
Co-authored papers 2
Antonio Artigas
Institute of Health Carlos III
Co-authored papers 2
G Clermont
University of Pittsburgh
Co-authored papers 1
Walter T Linde-Zwirble
The CRISMA Laboratory (Clinical Research, University of Pittsburgh
Co-authored papers 1
Ville Pettil??
University of Helsinki and Helsinki University Hospital
Co-authored papers 1
Ben van Hout
University of Sheffield
Co-authored papers 1
Andre C Kalil
University of Nebraska School of Medicine
Co-authored papers 1
Eugene Wesley Ely
Vanderbilt University Medical Center
Co-authored papers 1
Daniel E Ball
Lilly Research Laboratories
Co-authored papers 1
Release 1.2